Release 5 R6 Ballot (2nd Draft)

This page is part of the FHIR Specification (v5.0.0: R5 - STU v6.0.0-ballot2: Release 6 Ballot (2nd Draft) (see Ballot Notes ). This is the The current published version in it's permanent home (it will always be available at this URL). is 5.0.0 . For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Example MedicationDispense/meddisp0322 (XML)

Pharmacy Work Group Maturity Level : N/A Standards Status : Informative Compartments : Encounter , Patient , Practitioner

Raw XML ( canonical form + also see XML Format Specification )

Jump past Narrative

Dispense for Dilantin Oral Suspension (NDC code) - completed (id = "meddisp0322") 

<?xml version="1.0" encoding="UTF-8"?>

<MedicationDispense xmlns="http://hl7.org/fhir">
    
    display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border:
       1px solid #8da1b4; border-radius: 5px; line-height: 60%
   
       
       
           
           
           
       
       
   
    
        
        
    
    
        
            
        
    
    
        
    
    
        
            
            
            
        
    
    
        
        
        
    
    
        
        
        
        
    
    
    
    
        
        
        
            
                
                
                
            
        
        
            
                
                
                
            
        
        
            
                
                    
                    
                    
                
            
            
                
                
                
                
            
        
     

  <id value="meddisp0322"/> 
  <status value="completed"/> 
  <medication> 
    <concept> 
      <coding> 
        <system value="http://hl7.org/fhir/sid/ndc"/> 
        <code value="0071-2214-20"/> 
        <display value="Dilantin-125, 237 mL in 1 BOTTLE, GLASS (0071-2214-20) (package)"/> 
      </coding> 
    </concept> 
  </medication> 
  <subject> 
    <reference value="Patient/pat1"/> 
    <display value="Donald Duck"/> 
  </subject> 
  <performer> 
    <actor> 
      <reference value="Practitioner/f006"/> 
    </actor> 
  </performer> 
  <authorizingPrescription> 
    <reference value="MedicationRequest/medrx0312"/> 
  </authorizingPrescription> 
  <type> 
    <coding> 
      <system value="http://terminology.hl7.org/CodeSystem/v3-ActCode"/> 
      <code value="RFP"/> 
      <display value="Refill - Part Fill"/> 
    </coding> 
  </type> 
  <quantity> 
    <value value="360"/> 
    <system value="http://unitsofmeasure.org"/> 
    <code value="ml"/> 
  </quantity> 
  <daysSupply> 
    <value value="30"/> 
    <unit value="Day"/> 
    <system value="http://unitsofmeasure.org"/> 
    <code value="d"/> 
  </daysSupply> 
  <whenPrepared value="2015-01-16T07:13:00+05:00"/> 
  <whenHandedOver value="2015-01-18T07:13:00+05:00"/> 
  <dosageInstruction> 
    <sequence value="1"/> 
    <text value="100mg (4ml) three times daily"/> 
    <timing> 
      <repeat> 
        <frequency value="3"/> 
        <period value="1"/> 
        <periodUnit value="d"/> 
      </repeat> 
    </timing> 
    <route> 
      <coding> 
        <system value="http://snomed.info/sct"/> 
        <code value="26643006"/> 
        <display value="Oral Route (qualifier value)"/> 
      </coding> 
    </route> 
    <doseAndRate> 
      <type> 
        <coding> 
          <system value="http://terminology.hl7.org/CodeSystem/dose-rate-type"/> 
          <code value="ordered"/> 
          <display value="Ordered"/> 
        </coding> 
      </type> 
      <doseQuantity> 
        <value value="4"/> 
        <unit value="ml"/> 
        <system value="http://unitsofmeasure.org"/> 
        <code value="ml"/> 
      </doseQuantity> 
    </doseAndRate> 
  </dosageInstruction> 


</

MedicationDispense

>

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.